AbbVie Alliance for Genomic Discovery Adds Major Biopharma Partners to Help Fund WGS-Based Biobank Funding from AbbVie, Amgen, AstraZeneca, Bayer, and Merck will enable DeCode Genetics to sequence an additional 215,000 samples for the alliance. AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project Premium The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery. Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. New Drug Approvals More Likely With Supporting Human Genetic Evidence AbbVie researchers validated and extended a previous study to find different types of genetic evidence have varying influences on approval prospects. Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials Amgen's latest deal with a pharma company will see its clonoSeq assay used for minimal residual disease testing in a clinical trial for venetoclax. Aug 7, 2019 Genomics Medicine Ireland Aims to Allay Data Security Concerns While Seeking New Partnerships Premium Jan 8, 2018 Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK Biobank Samples Dec 19, 2017 Finnish Researchers, Pharma Partners to Genotype 500K Samples as Part of New €59M Study Premium Oct 12, 2017 NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative Aug 24, 2017 Researchers Identify New Treatment Target for Esophageal Cancer Jan 9, 2017 AbbVie, WuXi Nextcode, Genomics Medicine Ireland Form Population Genomics Alliance Dec 8, 2016 AbbVie Pursues Phase III Veliparib Study in BRCA Mutated Breast Cancer After Phase II Survival Trend Premium Apr 13, 2016 AbbVie Venclexta, Abbott CDx Approval Provide Docs Opportunity to Individualize CLL Treatment Premium Feb 23, 2016 AbbVie to Use Myriad CDx to Support PARP Inhibitor Development Breaking News Research Triangle Institute Partners With GeneDx, Illumina on NGS-based Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO Euformatics Forms Distribution Partnership for Eastern Europe With Bulgaria's Elta 90 Oxford Nanopore, University of Queensland Partner for Sequencing-Based mRNA Vaccine Quality Control The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.